UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052040
Receipt number R000059373
Scientific Title Effect of General Anesthetics on Perioperative Serum Cytokine Level Changes: An Open-Label Randomized Comparative Trial
Date of disclosure of the study information 2023/09/01
Last modified on 2024/10/30 07:20:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of Anesthetic Drugs on Serum Cytokine Levels Before and After Surgery

Acronym

Impact of Anesthetic Drugs on Serum Cytokine Levels Before and After Surgery

Scientific Title

Effect of General Anesthetics on Perioperative Serum Cytokine Level Changes: An Open-Label Randomized Comparative Trial

Scientific Title:Acronym

Effect of General Anesthetics on Perioperative Serum Cytokine Level Changes: An Open-Label Randomized Comparative Trial

Region

Japan


Condition

Condition

Patients undergoing robot-assisted radical prostatectomy

Classification by specialty

Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We comprehensively analyzed cytokines in blood collected from the arterial line before the incision and after the completion of surgery. Using unsupervised clustering methods such as principal component analysis and Ward's method, we examined the differences in cytokine changes induced by anesthetic drugs.

Basic objectives2

Others

Basic objectives -Others

The secondary outcome measure was all adverse events occurring until discharge.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Changes in serum cytokine levels before and after surgery

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

During surgery, sevofluran will be assigned as the anesthetic agent.

Interventions/Control_2

During surgery, desflurane will be assigned as the anesthetic agent.

Interventions/Control_3

During surgery, propofol will be assigned as the anesthetic agent.

Interventions/Control_4

During surgery, remimazolam will be assigned as the anesthetic agent.

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

Adult males scheduled for robot-assisted radical prostatectomy at our institution with a systemic status classified as ASA class I or II. Candidates should be assessed and deemed appropriate by the attending anesthesiologist to undergo anesthesia management using a combination of general anesthesia with epidural and the insertion of an arterial line. Participants must have the ability to give informed consent. Furthermore, the attending anesthesiologist should be confident in administering safe anesthesia with any of the agents: sevoflurane, desflurane, propofol, or remimazolam.

Key exclusion criteria

Individuals with a history of allergies to anesthetic agents, those with a family history of malignant hyperthermia, patients using immunosuppressive agents preoperatively, individuals with a BMI less than 18.5 or greater than 30, those with a compromised systemic status (ASA class III or higher), patients with a preoperative hemoglobin level below 12.0 g/dL, and any other individuals deemed ineligible by the principal investigator.

Target sample size

48


Research contact person

Name of lead principal investigator

1st name Matsuo
Middle name
Last name Mitsuhiro

Organization

University of Toyama

Division name

Department of anesthesiology

Zip code

930-0194

Address

2630 Sugitani,Toyama, Toyama

TEL

0764347377

Email

mmatsuo@med.u-toyama.ac.jp


Public contact

Name of contact person

1st name Matsuo
Middle name
Last name Mitsuhiro

Organization

University of Toyama

Division name

Department of anesthesiology

Zip code

930-0194

Address

2630 Sugitani,Toyama, Toyama

TEL

0764347377

Homepage URL


Email

mmatsuo@med.u-toyama.ac.jp


Sponsor or person

Institute

University of Toyama

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Toyama

Address

2630 Sugitani,Toyama, Toyama

Tel

0764347377

Email

mmatsuo@med.u-toyama.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 08 Month 10 Day

Date of IRB

2023 Year 08 Month 10 Day

Anticipated trial start date

2023 Year 09 Month 01 Day

Last follow-up date

2024 Year 10 Month 30 Day

Date of closure to data entry

2024 Year 10 Month 30 Day

Date trial data considered complete

2024 Year 10 Month 30 Day

Date analysis concluded

2025 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2023 Year 08 Month 29 Day

Last modified on

2024 Year 10 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059373